Endocannabinoid biosynthetic enzymes regulate pain response via LKB1–AMPK signaling
Proceedings of the National Academy of Sciences · 26.12.2023 · 120 (52)
DOI: 10.1073/pnas.2304900120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 18.12.2023. Verfasst von Miaomiao Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Virginia, Charlottesville, VA 22904. Hauptthemen laut MEDLINE: Endocannabinoids, Glycerides. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, NHLBI NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Diacylglycerol lipase-beta (DAGLβ) serves as a principal 2-arachidonoylglycerol (2-AG) biosynthetic enzyme regulating endocannabinoid and eicosanoid metabolism in immune cells including macrophages and dendritic cells. Genetic or pharmacological inactivation of DAGLβ ameliorates inflammation and hyper-nociception in preclinical models of pathogenic pain. These beneficial effects have been assigned principally to reductions in downstream proinflammatory lipid signaling, leaving alternative mechanisms of regulation largely underexplored. Here, we apply quantitative chemical- and phospho-proteomics to find that disruption of DAGLβ in primary macrophages leads to LKB1–AMPK signaling activation, resulting in reprogramming of the phosphoproteome and bioenergetics. Notably, AMPK inhibition reversed the antinociceptive effects of DAGLβ blockade, thereby directly supporting DAGLβ–AMPK crosstalk in vivo. Our findings uncover signaling between endocannabinoid biosynthetic enzymes and ancient energy-sensing kinases to mediate cell biological and pain responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Virginia, Charlottesville, VA 22904.
- Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA 23298.
- Department of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA 22908.
- Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23298.
- Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA 22908.
- University of Virginia Cancer Center, Cancer Biology Program, University of Virginia, Charlottesville, VA 22903.
ORCID-Profile: Miaomiao Chen, Timothy B Ware, Karan H Muchhala, Vlad Serbulea, Clint M Upchurch, Hamid I Akbarali, Ku-Lung Hsu
Förderung
- NIDA NIH HHS
- NHLBI NIH HHS
- NCI NIH HHS
- NIDDK NIH HHS
- NIGMS NIH HHS
- HHS | NIH | National Institute on Drug Abuse
- HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases
- HHS | NIH | National Institute of General Medical Sciences
Zitieren
APA
Chen, M., Shin, M., Ware, T. B., Donvito, G., Muchhala, K. H., Mischel, R., Mustafa, M. A., Serbulea, V., Upchurch, C. M., Leitinger, N., Akbarali, H. I., Lichtman, A. H., & Hsu, K. L. (2023). Endocannabinoid biosynthetic enzymes regulate pain response via LKB1–AMPK signaling. Proceedings of the National Academy of Sciences, 120(52). https://doi.org/10.1073/pnas.2304900120
Vancouver
Chen M, Shin M, Ware TB, Donvito G, Muchhala KH, Mischel R, et al. Endocannabinoid biosynthetic enzymes regulate pain response via LKB1–AMPK signaling. Proceedings of the National Academy of Sciences. 2023;120(52). doi:10.1073/pnas.2304900120
BibTeX
@article{Chen2023,
author = {Chen, Miaomiao and Shin, Myungsun and Ware, Timothy B and Donvito, Giulia and Muchhala, Karan H and Mischel, Ryan and Mustafa, Mohammed A and Serbulea, Vlad and Upchurch, Clint M and Leitinger, Norbert and Akbarali, Hamid I and Lichtman, Aron H and Hsu, Ku-Lung},
title = {Endocannabinoid biosynthetic enzymes regulate pain response via LKB1–AMPK signaling},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
volume = {120},
number = {52},
doi = {10.1073/pnas.2304900120}
}
EUVIMED